Product Information
ESCITALOPRAM 10 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0429 per EA under NDC 59746028010. Its NADAC has been published 86 times since May 15, 2024.
FDA first approved this application on Sep 12, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746028010
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
12/17/2025
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA202280FDA Approved
9/12/2012
TE Code
AB
On Market Since
12/1/2023
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 10 MG TABLET has been published 86 times since May 15, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0429 per EA |
|---|---|
| All-time high | $0.0493 (Nov 13, 2024) |
| All-time low | $0.0345 (Nov 20, 2024) |
| 52-week high | $0.0446 |
| 52-week low | $0.0425 |
| Median price | $0.0444 |
| Average price | $0.0441 |
| Largest weekly change | -29.9% (Nov 20, 2024) |
| Weeks tracked | 86 |
| Tracking since | May 15, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-3.7%
3Y
N/A
5Y
N/A
All
+1.2%
Last surveyed Dec 31, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 10 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0429 per EA (NDC 59746028010), effective Dec 31, 2025.
How has the price of ESCITALOPRAM 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 86 weekly CMS publications since May 15, 2024.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 10 MG TABLET?
Since May 15, 2024, the NADAC for ESCITALOPRAM 10 MG TABLET has ranged from a low of $0.0345 (Nov 20, 2024) to a high of $0.0493 (Nov 13, 2024), with a median of $0.0444 per EA.
Are there cheaper alternatives to ESCITALOPRAM 10 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESCITALOPRAM 10 MG TABLET, is $0.0394 per EA — about 8% below ESCITALOPRAM 10 MG TABLET.
Who manufactures ESCITALOPRAM 10 MG TABLET?
ESCITALOPRAM 10 MG TABLET (NDC 59746028010) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.